Literature DB >> 6895387

Interaction of Shigella shigae cytotoxin with receptors on sensitive and insensitive cells.

K Eiklid, S Olsnes.   

Abstract

The effect of a cytotoxin isolated from Shigella shigae has been tested on different cell lines. HeLa S3 cells, as well as some other human carcinoma cells, were killed by picomolar to femtomolar concentrations of the pure toxin, whereas certain other human carcinoma cells and a variety of non-epithelial cells from human tissue and from various animal tissues were resistant to-nanomolar concentrations of the toxin. Binding studies with 125 I-labelled Shigella shigae cytotoxin showed that the sensitive HeLa S3 cells contain 1.3 x 10(6) binding sites per cell, whereas in an insensitive HeLa cell line 2.6 x 10(5) sites per cell were measured. In all cases the apparent association constant, Ká was found to be about 10(10) M-1. The binding occurred fairly rapidly, whereas dissociation of bound toxin occurred at a very slow rate, even in the presence of excess unlabaled toxin. All toxin sensitive cell lines bound similar amounts of toxin as HeLa S3 cells, whereas some of the resistant cell lines did not contain measurable amounts of toxin receptors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6895387     DOI: 10.3109/10799898009044098

Source DB:  PubMed          Journal:  J Recept Res        ISSN: 0197-5110


  25 in total

1.  Shiga toxin 1 from Escherichia coli blocks activation and proliferation of bovine lymphocyte subpopulations in vitro.

Authors:  C Menge; L H Wieler; T Schlapp; G Baljer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.

Authors:  T Waddell; A Cohen; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.

Authors:  J E Samuel; L P Perera; S Ward; A D O'Brien; V Ginsburg; H C Krivan
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

4.  Localization of potential binding sites for the edema disease verotoxin (VT2e) in pigs.

Authors:  T E Waddell; B L Coomber; C L Gyles
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

5.  Isolation of Shiga toxin-resistant Vero cells and their use for easy identification of the toxin.

Authors:  U Kongmuang; T Honda; T Miwatani
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

Review 6.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

7.  Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin.

Authors:  G Fuchs; M Mobassaleh; A Donohue-Rolfe; R K Montgomery; R J Grand; G T Keusch
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

8.  Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.

Authors:  J E Brown; D E Griffin; S W Rothman; B P Doctor
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Enzyme-linked immunosorbent assay to detect Shiga toxin of Shigella dysenteriae and related toxins.

Authors:  U Kongmuang; T Honda; T Miwatani
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

10.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.